Achieving a 100 % Market Share in Clinical Trials

Today's guest is Charles Fisher, Founder & CEO at Unlearn.AI in San Francisco. Founded in 2017, Unlearn.AI helps biopharma companies develop drugs more ethically and efficiently by leveraging generative machine learning models to reduce the number of patients required for placebo controls in clinical trials. They enable clinical trials that are twice as fast, require fewer patients, produce better evidence about therapeutic efficacy, and in which fewer patients need to be given placebos.

In the episode, Charles will tell you about:

The motivation for setting up Unlearn.AI,

How they have evolved and the interesting work they do within healthcare,

How the Data Science team is structured for success,

Challenges they need to overcome,

Plans for growth and what the future looks like and

Advice to Data Scientists transitioning from academia into industry